Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorothyazinone Safety and Pharmacokinetics in Healthy Volunteers
NCT03205462Phase 1Completed
- Start
- Aug 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of Fluorothiazinone in bacterial infection (3 arms). Primary endpoint: Product safety evaluation by assessing its impact on vital signs and clinical laboratory test results at 3 months. Started Aug 2017; status: completed.
02
Drugs
Fluorothiazinone
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03205462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03205462.